PRINCETON, N.J., April 23 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that the company plans to release its financial results for the first quarter ended March 31, 2008, after the close of market on Wednesday, May 7, 2008. The company will conduct a webcast and conference call at 5:00 p.m. EDT on the same day.
Dr. Joseph A. Mollica, Chairman of the Board and Acting Chief Executive
Officer, Mr. Brian M. Posner, Executive Vice President and Chief Financial
Officer, and Dr. Rene Belder, Senior Vice President, Clinical and
Regulatory Affairs, will host the call. Forward-looking and other material
information may be discussed on this conference call.
Date: May 7, 2008
Time: 5:00 p.m. EDT
Webcast: Accessible via the company's website at
US/Canadian participants: 877-681-3367
International participants: 719-325-4855
Confirmation code: 9717744
Name of conference: Pharmacopeia's First Quarter 2008 Financial Results
A replay of the conference call can be accessed by dialing toll-free (888) 203-1112 in the U.S., or (719) 457-0820 outside the U.S. The access code for the replay is 9717744. Replay of the webcast will also be accessible on Pharmacopeia's website on the Investors page at http://www.pharmacopeia.com. The replays will be available for two weeks.
Pharmacopeia is a clinical development stage biopharmaceutical company
dedicated to discovering
Copyright©2008 PR Newswire.
All rights reserved